mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.008 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |